Esther Quintana Gallego-rekin lankidetzan egindako argitalpenak (7)

2023

  1. Elexacaftor/ Tezacaftor/ Ivacaftor en pacientes con fibrosis quística y enfermedad pulmonar avanzada: experiencia nacional

    Revista española de patología torácica, Vol. 35, Núm. 1, pp. 46-47

  2. Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease

    Archivos de Bronconeumologia, Vol. 59, Núm. 9, pp. 556-565

2022

  1. Real Life With Tezacaftor and Ivacaftor in Adult Patients With Cystic Fibrosis: Spanish Multicenter Study

    Archivos de Bronconeumologia, Vol. 58, Núm. 9, pp. 672-674

2020

  1. Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey

    Respiratory Medicine, Vol. 170

2018

  1. Cost of hospitalizations due to exacerbation in patients with non-cystic fibrosis bronchiectasis

    Respiration, Vol. 96, Núm. 5, pp. 406-416

2016

  1. Bronchopulmonary infection-colonization patterns in Spanish cystic fibrosis patients: Results from a national multicenter study

    Journal of Cystic Fibrosis, Vol. 15, Núm. 3, pp. 357-365

  2. Depression and anxiety symptoms in Spanish adult patients with cystic fibrosis: Associations with health-related quality of life

    General Hospital Psychiatry, Vol. 40, pp. 39-46